NYSE:ABTMedical Equipment
Abbott (ABT) Stock Still Looks Cheap On Cash Flow And Earnings
Abbott Laboratories stock has fallen about 27.4% over the past year, yet both its intrinsic value estimate using a Discounted Cash Flow (DCF) approach and the market multiple checks point to the shares trading at a discount to what the underlying business may be worth.
The share price decline of roughly 27.4% over the past year means investors are looking at a healthcare giant whose market value has moved well below where it stood, even as its business profile remains diversified across...